Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Barrera C, Corredor G, Viswanathan VS, Ding R, Toro P, Fu P, et al. Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer. NPJ Precis Oncol. 2023;7(1):52.

Ahmad M, Warren LA, Naumaan A, Schatz-Siemers N. The Placenta in Congenital Langerhans Cell Histiocytosis: A Case Report of Unusual Involvement of Chorionic Plate and Umbilical Vein. Pediatr Dev Pathol. 2023;26(5):482-485.

Stangl-Kremser J, Kowalczyk K, Schaeffer EM, Allaf M, Scherr D, Yang X, et al. Study protocol for a prospective, multi-centered randomized controlled trial comparing pelvic fascia-sparing radical prostatectomy with conventional robotic-assisted prostatectomy: The PARTIAL trial. Contemp Clin Trials. 2023;128:107168.

Sasset L, Chowdhury KH, Manzo OL, Rubinelli L, Konrad C, J Maschek A, et al. Sphingosine-1-phosphate controls endothelial sphingolipid homeostasis via ORMDL. EMBO Rep. 2023;24(1):e54689.

Choi IY, Ling J, Zhang J, Helmenstine E, Walter W, Bergman R, et al. The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts. Res Sq. 2023.

Geizhals S, Magro CM, Lipner SR. Accessory Tragus Resembling a Hair Follicle Nevus. Skinmed. 2023;21(1):37.

Callegari K, Dash S, Uchida H, Shingai Y, Liu C, Khodarkovskaya A, et al. Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates. Proc Natl Acad Sci U S A. 2023;120(16):e2205786120.

Magahis PT, Westerveld D, Simons M, Hissong E, Carr-Locke DL, Sampath K, et al. EUS-guided liver biopsy using a novel hydrostatic stylet technique. VideoGIE. 2023;8(3):104-106.

Sloan SL, Brown F, Long M, Weigel C, Koirala S, Chung J-, et al. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma. Blood. 2023;142(10):887-902.

Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, et al. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023;15:17588359231152844.